VeriMomVeriMom

resveratryl tris-ethylhexanoate é seguro durante a gravidez?

No EU Annex II/III listing or harmonised CLP classification was found for this substance; no SCCS/CIR safety assessment specific to resveratryl tris‑ethylhexanoate was found. However, it is derived from resveratrol, a phytoestrogen with in vitro estrogenic activity and some reported endocrine‑related effects in the literature (resveratrol class = structural/biochemical alert), so a class/structural‑alert flag is applied (h=1). Mechanistically this is theoretical only (m=1) because the concern is based on parent resveratrol’s in vitro endocrine activity and possible metabolic release — no direct in vivo developmental/reproductive studies on this specific ester were located. Absorption from topical use is likely low but measurable (e=1) given the ester is lipophilic and intended for topical formulations; no dermal absorption data for this exact ester were found.

Ingredientes
resveratryl tris-ethylhexanoate
RISCO MÉDIO
67
/100
0

Alternativas seguras ao resveratryl tris-ethylhexanoate na gravidez | VeriMom

Related ingredients

Frequently asked questions

resveratryl tris-ethylhexanoate é seguro durante a gravidez?
No EU Annex II/III listing or harmonised CLP classification was found for this substance; no SCCS/CIR safety assessment specific to resveratryl tris‑ethylhexanoate was found. However, it is derived from resveratrol, a phytoestrogen with in vitro estrogenic activity and some reported endocrine‑related effects in the literature (resveratrol class = structural/biochemical alert), so a class/structural‑alert flag is applied (h=1). Mechanistically this is theoretical only (m=1) because the concern is based on parent resveratrol’s in vitro endocrine activity and possible metabolic release — no direct in vivo developmental/reproductive studies on this specific ester were located. Absorption from topical use is likely low but measurable (e=1) given the ester is lipophilic and intended for topical formulations; no dermal absorption data for this exact ester were found.
resveratryl tris-ethylhexanoate é seguro durante a amamentação?
Same justification as pregnancy: no direct reproductive/breastmilk transfer data for this specific ingredient. Because it is a resveratrol derivative, a conservative structural/class alert is applied (h=1) and mechanism remains theoretical (m=1). Exposure from topical application to the breast is expected to be low but measurable (e=1); no data were found on transfer into breastmilk for this ester.
resveratryl tris-ethylhexanoate é seguro para a pele do bebê?
No infant‑specific safety studies for resveratryl tris‑ethylhexanoate were identified. Hazard and mechanism scores remain the same as adult (h=1, m=1) because there is no infant‑specific evidence of increased hazard or a different mechanism. Exposure score is increased by +1 (e=2) to account for higher per‑weight exposure and immature barrier in 0–3‑year‑old skin when the ingredient has measurable dermal absorption in adults.
Como o VeriMom pontua resveratryl tris-ethylhexanoate?
O VeriMom pontua resveratryl tris-ethylhexanoate em 67/100 (risco médio) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
Quais são as alternativas seguras a resveratryl tris-ethylhexanoate na gravidez?
Veja nossa lista curada de alternativas seguras a resveratryl tris-ethylhexanoate com base em função semelhante e classificação sem riscos conhecidos.

Verifique qualquer rótulo em 2 segundos

Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.

Aviso Médico

Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.

Tenha a experiência completa no app VeriMom